510(k) Report

510(k) · Cleared

Cleared

Liquichek Ana Control, Speckled Pattern, Model 202

K984400510(k) TraditionalCleared Dec 18, 19989-day reviewClass II21 CFR 866.5100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bio-Rad · DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control

Cleared on Dec 18, 1998 as substantially equivalent to K813592 (Kallestad Laboratories, Inc., 1982) after a 9-day review. Its family tree reaches back 1 generation to 1982.

Decided
Dec 18, 1998
Review
9 days
Class
Class II
Product code
DHN
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K813592 (1982). No later device cites it as a predicate yet.

K813592 · Quantafluor Fluorescent Test Reagents · Kallestad Laboratories, Inc. · 1982 · recalled19801985199019952000
  1. Root · 1 generation backK813592 Quantafluor Fluorescent Test ReagentsKallestad Laboratories, Inc. · 1982 · Recalled
  2. This deviceK984400 Liquichek Ana Control, Speckled Pattern, Model 202Bio-Rad · 1998
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K813592Quantafluor Fluorescent Test ReagentsKallestad Laboratories, Inc.19822
0 (this device)K984400Liquichek Ana Control, Speckled Pattern, Model 202Bio-Rad1998—
FIG. 1 — Lineage of K984400, 1982–1998Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DHN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K813592Quantafluor Fluorescent Test Reagents
Summary page 1
…igen, Control. ¥ Devices to Which Substantial Equivalence is Claimed Kallestad Quantafluor Autoantibody Positive Control Sanofi Diagnostics Pasteur Chaska, Minnesota K813592 Statement of Intended Use Liquichek ANA Control, Speckled Pattern is intended for use as an unassayed quality control to monitor…
Kallestad Laboratories, Inc.19822

Also cleared against K813592: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • 3 other devices also cite its predicate K813592.

How does its category compare?

All DHN devices

DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DHN

1in 2022

2007: 12012: 12014: 12015: 22016: 22018: 12022: 1
2007high 2 (2015) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DHN

Too few DHN 510(k)s in any year since 2007 to give a median.

Recalls per year · DHN

1in 2011

2008: 22010: 12011: 1
2007high 2 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DHN

No MAUDE report names DHN since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—20
20090—00
20100—10
20110—10
20121—00
20130—00
20141—00
20152—00
20162—00
20170—00
20181—00
20190—00
20200—00
20210—00
20221—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

Liquichek ANA Control, Speckled Pattern is intended for use as an unassayed quality control to monitor indirect immunofluorescent testing of antinuclear antibodies (ANA).

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K984400: Liquichek Ana Control, Speckled Pattern, Model 202.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K984400

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026